Harden, E., Lucas, V. S., Proia, A., & Silberman, H. R. (1982). Hemolytic uremic syndrome during therapy with mitomycin-C (MMC) plus 5-fluorouracil (5-FU). Proceedings of the American Society of Clinical Oncology, Vol. 1.

Harden, E., V. S. Lucas, A. Proia, and H. R. Silberman. “Hemolytic uremic syndrome during therapy with mitomycin-C (MMC) plus 5-fluorouracil (5-FU).” Proceedings of the American Society of Clinical Oncology Vol. 1 (January 1, 1982).

Harden E, Lucas VS, Proia A, Silberman HR. Hemolytic uremic syndrome during therapy with mitomycin-C (MMC) plus 5-fluorouracil (5-FU). Proceedings of the American Society of Clinical Oncology. 1982 Jan 1;Vol. 1.

Harden, E., et al. “Hemolytic uremic syndrome during therapy with mitomycin-C (MMC) plus 5-fluorouracil (5-FU).” Proceedings of the American Society of Clinical Oncology, vol. Vol. 1, Jan. 1982.

Harden E, Lucas VS, Proia A, Silberman HR. Hemolytic uremic syndrome during therapy with mitomycin-C (MMC) plus 5-fluorouracil (5-FU). Proceedings of the American Society of Clinical Oncology. 1982 Jan 1;Vol. 1.